Emotional state of patients with relapsing-remitting MS treated with interferon beta-1b
Cecilia Borrás(Hebron University), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), J. Porcel(Vall d'Hebron Hospital Universitari), Maite Barrios(Vall d'Hebron Hospital Universitari), Mar Tintoré(Vall d'Hebron Hospital Universitari), Jordi Río(Universitat Autònoma de Barcelona)
Cited by 62
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k